Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02150863 · ClinicalTrials.gov registry record · NA
Treatment of Field Cancerization for Reduction in Tumor Burden - A Prospective Study
A NA study, sponsored by Massachusetts General Hospital.
- Terminated
- Registry status
- NA
- Development phase
- 1
- Enrollment target
NCT02150863: Clinical Trial NA study, sponsored by Massachusetts General Hospital.
NCT02150863 is a NA study that was terminated before completion, run by Massachusetts General Hospital. The registered enrollment target is 1 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02150863, a NA study, was terminated before completion, sponsored by Massachusetts General Hospital.
- TERMINATED
- Registry status
- NA
- Development phase
- 1 participants
- Enrollment target
Study Summary
This project aims to treat field cancerization ( pre-skin cancers) in a manner that will reduce the future pre-skin cancers and non-melanoma skin cancers in patients with significant photodamage. This is 3 year prospective, randomized, controlled comparison of a single treatment with carbon dioxide laser resurfacing vs. carbon dioxide resurfacing plus autologous epidermal skin graft from a non sun exposed site vs. control. Thirty subjects will receive treatment with each of the modalities. The primary measures of efficacy are (a) count of the number of actinic keratosis and non melanoma skin cancers, (b) blinded evaluation of severity from standard digital photographs taken before and after the treatments, and (c) change in histology before and after treatment. Safety measures include (a) pain, (b) scarring, (c) wound healing, (d) and infection
Primary Outcome
This is done at every visit over the 3 year period
Interventions
- DEVICE Ultrapulse Carbon Dioxide Laser
- DEVICE Cellutome epidermal harvesting system
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1 participants |
| Start Date | 2014-08 |
| Est. Completion | 2018-04 |
| Phase | NA |
Why NCT02150863 stopped before completion
NCT02150863 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 1 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower).
The record links to 0 conditions, and to 2 interventions - of which Ultrapulse Carbon Dioxide Laser is the first listed.
NCT02150863 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02150863 about?
NCT02150863 is a clinical study titled "Treatment of Field Cancerization for Reduction in Tumor Burden - A Prospective Study". This project aims to treat field cancerization ( pre-skin cancers) in a manner that will reduce the future pre-skin cancers and non-melanoma skin cancers in patients with significant photodamage. This is 3 year prospective, randomized, controlled comparison of a single treatment with carbon dioxide...
What is the current status of trial NCT02150863?
This trial is currently terminated. It is a NA study. The enrollment target is 1 participants. The study started on 2014-08. Estimated completion is 2018-04.
What interventions are being tested in trial NCT02150863?
The interventions under investigation include: Ultrapulse Carbon Dioxide Laser (DEVICE), Cellutome epidermal harvesting system (DEVICE).
Who is sponsoring clinical trial NCT02150863?
This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02150863's enrollment target sits among peer trials
1 2001st of 2000 the lowest of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia